Dr. Bernardo Dell’Osso. Born in Milan in 1978, he is currently Director of the Psychiatric Clinic of the Ospedale Sacco-Polo Universitario in Milan and Associate Professor of Psychiatry at the University of Milan.
Graduated in Medicine with honors at the Università degli Studi di Milano, he obtained his residency in Psichiatry with honors (2006) at the same institution. Since 2008, he has been employed at the Department of Mental Health of the Fondazione IRCCS Ca’ Granda Policlinico in Milan, Italy. He had completed the the first part of his residency at the Department of Psichiatry of the University of Pisa (Director Prof. G.B. Cassano). He then completed his third year of residency (2004-2005) at the Mount Sinai School of Medicine in New York as a postdoctoral research fellow, working for the Compulsive, Impulsive and Anxiety Disorders Program (Director Prof. E. Hollander), and collaborated on the first edition of the American Psychiatric Association Guidelines for Obsessive-Compulsive Disorder. In 2005, he completed a clinical fellowship in Transcranial Magnetic Stimulation at the Department of Biological Psychiatry of the Columbia University in New York (Director Prof. H. Sakheim). In 2009, he received the Fellowship Award from the European College of Neuropsychopharmacology (ECNP) and in 2013 he received a second Fellowship Award from the International Society of Bipolar Disorders (ISBD). He began an annual collaboration with the Stanford University in 2011 at the Department of Psychiatry and Behavioural Sciences in the Bipolar Disorders Clinic (Director Prof. T.A. Ketter) working in the field of bipolar disorders. He has been collaborating with the Stanford University since 2011 (Dean Prof. A. Schatzberg) and as a Scientific Advisor (Dean Prof. L. Roberts) since 2014.
He participates in numerous international collaborative research projects in the Bipolar Disorder (ISBD), Anxiety Disorders (ECNP-Anxiety Disorders Research Network Program) and Obsessive-Compulsive Spectrum Disorders fields, as well as being a member of the directory board of the International College of Obsessive-Compulsive Spectrum Disorders, known as ICOCS. His main fields of research are neuropsychobiology, genetics and epigenetics of affective disorders, obsessive-compulsive spectrum disorders, neuropsychopharmacological treatments and brain stimulation.
He is a member of several national and international scientific institutions (SOPSI, SINPF, ECNP, WFSBP, CINP) and he forms part of the editorial board of different international peer-reviewed journals including Comprehensive Psychiatry, the International Journal of Bipolar Disorders and CNS Spectrums.
He has authored more than 200 publications on national and international journals (230 Scopus, 200 Pubmed, Scopus H Index 38) and 6 books. Within an international research team, he participated for the University of Milan from 2011 to 2016 in the European Commission financed project Program FP7 Marie Curie, “EUSARNAD” (European and South African Research Network in Anxiety Disorders). Since 2017, he participates to the international research project COST (Horizon 2020) “EU-PUI” (European Network for Problematic Usage of the Internet).
Michael Van Ameringen, MD, FRCPC, is a Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University in Hamilton, Ontario, Canada. His research is focused on the psychopharmacology of Obsessive Compulsive Disorder (OCD), Obsessive Compulsive spectrum disorders Social Phobia, Generalized Anxiety Disorder, treatment resistance in OCD, Anxiety Disorders and comorbid Mood Disorders. Other research interests include the use of the internet for the assessment of Anxiety Disorders, the epidemiology of Post Traumatic Stress Disorder, the use of virtual reality in the treatment of anxiety disorders, and the relationship of Attention Deficit/Hyperactivity Disorder to Anxiety Disorders. He has been a member of the Steering Committee for the development of Canadian Anxiety Disorder Treatment Guidelines Initiative and is currently involved in writing an updated version. As well, he was a member of the World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders. He is a member of the Board of Directors and the Scientific Advisory Council of the Anxiety and Depression Association of America and is on the editorial board for the journal Depression and Anxiety. Dr. Van Ameringen has published widely in the area of OCD and Anxiety Disorders.